Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 34.67 2.06%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Supernus Pharmaceuticals Accounts Receivables 2011-2024 | SUPN

Annual Accounts Receivables Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
165 M 149 M 141 M 87.3 M 103 M 65.6 M 41.5 M 25.9 M 17.3 M 5.05 M 11 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
165 M 11 K 72.8 M

Quarterly Accounts Receivables Supernus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
145 M 152 M 148 M 144 M 142 M 137 M 144 M 165 M 164 M 158 M 145 M 149 M 134 M 137 M 127 M 141 M 141 M 141 M 141 M 87.3 M 87.3 M 87.3 M 87.3 M 103 M 103 M 103 M 103 M 65.6 M 65.6 M 65.6 M 65.6 M 41.5 M 41.5 M 41.5 M 41.5 M 25.9 M 25.9 M 25.9 M 25.9 M 17.3 M 17.3 M 17.3 M 17.3 M 5.05 M 5.05 M 5.05 M 5.05 M 11 K 500 K - - 128 K - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
165 M 11 K 82.8 M